NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Klarna Group plc (NYSE: KLAR) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Klarna’s September 2025 initial public offering (the “IPO”), of the important February 20, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you pur ...

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Plug Power Inc. (NASDAQ: PLUG) between January 17, 2025 and November 13, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 3, 2026. SO WHAT: If you purchased Plug Power securities during the Class Period you may be ent ...

New York, New York--(Newsfile Corp. - February 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Phoenix Education Partners, Inc. (NYSE: PXED) resulting from allegations that Phoenix Education may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Phoenix Education securities you may be entitled to compensation without payment of any out of pocket fees or ...

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of Picard Medical, Inc. for the period between September 2, 2025, and October 31, 2025, due to alleged misleading statements and undisclosed material facts regarding the company's operations and securities trading [1]. Summary by Sections Class Action Announcement - A class action lawsuit has been filed against Picard Medical, Inc. for securities purchased during the specified Class Period [1]. - Investors wishing to serve as lead plaintiffs must file with the Court by April 13, 2026 [1][3]. Compensation Information - Investors who purchased Picard Medical securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Legal Representation - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - Investors have the option to select their own counsel or remain absent from the class at this stage [7]. Details of the Case - The lawsuit alleges that defendants made materially false and misleading statements and failed to disclose adverse facts about Picard's business and operations [5]. - Specific allegations include involvement in a fraudulent stock promotion scheme, insider trading through offshore accounts, and omission of critical information regarding stock price manipulation [5]. Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 [4]. - The firm has been recognized for its success in securities class action settlements and has a history of representing investors globally [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Varonis Systems, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Varonis common stock between February 4, 2025, and October 28, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The deadline to move the court to serve as lead plaintiff is March 9, 2026 [3]. Group 2: Case Background - The lawsuit alleges that Varonis made materially false and misleading statements regarding its ability to maintain Annual Recurring Revenue (ARR) projections while transitioning customers to a software-as-a-service (SaaS) model [5]. - It is claimed that Varonis was not adequately prepared to convince existing users of the benefits of the SaaS offering, leading to reduced ARR growth potential [5]. - The lawsuit asserts that the misleading statements about Varonis' business and prospects resulted in investor damages when the truth was revealed [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been recognized as a leader in the field [4].

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Beyond Meat, Inc. (NASDAQ: BYND) between February 27, 2025 and November 11, 2025, both dates inclusive (the “Class Period”), of the important March 24, 2026 lead plaintiff deadline. SO WHAT: If you purchased Beyond Meat securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrange ...

New York, New York--(Newsfile Corp. - February 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of American Depositary Shares ("ADS") of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023, and December 26, 2025. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 6, 2026.SO WHAT: If you purchased Mereo securities during the Class Period you may ...

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Ramaco Resources, Inc. (NASDAQ: METC) between July 31, 2025 and October 23, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2026. SO WHAT: If you purchased Ramaco securities during the Class Period you ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Klarna Group plc about a class action lawsuit related to Klarna's September 2025 IPO, with a lead plaintiff deadline set for February 20, 2026 [1][3]. Group 1: Class Action Details - Investors who purchased Klarna securities may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit alleges that the Registration Statement contained false or misleading statements regarding Klarna's loss reserves, which were understated, leading to investor damages when the true information became public [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action litigation [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. due to allegations of materially misleading business information issued by the company [1]. Financial Performance - On January 29, 2026, PennyMac reported its fourth quarter and full-year 2025 financial results, revealing a pretax income of $37.3 million for its servicing segment, a significant decrease from $157.4 million in the prior quarter and $87.3 million in the same quarter of 2024 [3]. - The report indicated that pretax income excluding valuation-related items was $47.8 million, down 70% from the previous quarter, primarily due to increased realization of mortgage servicing rights cash flows as lower mortgage rates led to higher prepayment activity [3]. Stock Market Reaction - Following the financial report, PennyMac's stock price dropped by $49.78 per share, or 33.3%, closing at $99.92 per share on January 30, 2026 [3]. Legal Action - Investors who purchased PennyMac securities may be entitled to compensation through a class action lawsuit being prepared by Rosen Law Firm, which operates on a contingency fee basis, meaning no out-of-pocket costs for investors [2]. - Interested investors can join the class action by submitting a form or contacting the law firm directly [2]. Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and being recognized for its success in the field [4].